ArticleScientific reports2025
Immunological role and prognostic value of ITGA3 and ITGA5 in oral squamous cell carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative multi-omics and radiogenomic profiling decodes NNK-related tumor remodeling and prognostic stratification in pancreatic cancer.International journal of surgery (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer, originating from the squamous cells of the oral mucosa. The global occurrence is significant and is closely linked to smoking, alcohol use, and HPV infection, with a generally poor prognosis, highlighting the importance of early detection and treatment. Integrins are heterodimeric transmembrane receptors composed of α and β subunits, forming a recognized family of about 24 subtypes. ITGA3 and ITGA5, integrin family members, are crucial for cytoskeletal organization, cell migration, proliferation, and survival. ITGA3 acts as a cell membrane adhesion molecule, engaging with laminin family extracellular matrix proteins linked to tumors. ITGA5 and β1 combine to form a receptor for extracellular fibronectin, playing a role in malignant tumor cells and vasculature. Our study identified that ITGA3 and ITGA5 were overexpressed in oral cancer tissues, correlating with a significantly poorer prognosis for patients exhibiting high levels of these integrins. Further, we found that ITGA3 and ITGA5 were associated with the infiltration of a variety of immune cells as well as with the expression of a variety of immune checkpoints and ferroptosis-related genes. Our findings indicate that ITGA3 and ITGA5 expression levels are associated with the sensitivity to commonly used oral cancer treatments. These findings suggest that ITGA3 and ITGA5 could be potential targets for the prognosis, diagnosis, and treatment of OSCC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.